The largest database of trusted experimental protocols

31 protocols using hmb45

1

Comprehensive Immunohistochemical Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed on formalin-fixed paraffin-embedded tissue using 4 μm sections cut from paraffin blocks. Staining was performed using a fully automated system (Benchmark ULTRA, Ventana Medical Systems, Tuscon, AZ, USA) and the following antibodies were used: NTRK1 (Ab76291, 1:1,500, ABCAM), SOX10 (383A-75,1:50, CELL MARQUE), S100 (Z0311, 1:8,000, DAKO), H3 (9733, 1:100, CELL SIGNALING), CD34 (790-2927, VENTANA), SMA (VPS281, 1:50, VECTOR), Desmin (760-2513, VENTANA), Melan A (790-2990, VENTANA), STAT6 (SC-621, 1:2,500, SANTA CRUZ) and HMB45 (M0634, 1:100, DAKO).
+ Open protocol
+ Expand
2

Immunohistochemical Profiling of Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical (IHC) staining was performed on representative 4-μm-thick formalin-fixed, paraffin-embedded (FFPE) tumor tissue blocks for the five cases using the Leica BOND-MAX™ system (Leica Biosystems, Wetzlar, Germany) according to the manufacturer’s protocol. We used antibodies for the ER (6F11, 1:300, Novocastra, New Castle, United Kingdom, 1:300), PR (clone 16, Novocastra, 1:1200), premelanosome protein (HMB-45, Dako, Carpinteria, CA, USA, 1:80), cytokeratin (PAN CK) (AE1/AE3, Dako, 1:500), CD 20 (L26, Novocastra, 1:800), CD 3 (polyclonal, Dako, 1:300), leukocyte common antigen (CD 45 RB) (2B11 + PD7/26, Dako, 1:1000) and CD 56 (CD564, Novocastra, 1:200).
+ Open protocol
+ Expand
3

Immunohistochemical Staining of Paraffin Sections

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin sections were incubated at 60 °C for 2 h and afterwards dehydrated with xylene and decreasing ethanol concentration, followed by distilled water. Antigen retrieval was performed using 10 mM sodium citrate solution (pH6) for 30 min in a water bath at 95 °C. The endogenous peroxidase activity of the sections was blocked by using 3% H2O2 for 10 min. Antigen detection, including blocking of background staining, was performed using a ZytoChem Plus HRP Polymer Kit (Zytomed Systems GmbH, Berlin, Germany). Tissue sections were incubated with primary antibodies for 30 min at 37 °C (Ki67 monoclonal antibody 1:10 (SP6, Thermo Fisher Scientific, Rockford, IL, USA ), MelanA monoclonal antibody 1:50 (A103, Abcam, Cambridge, UK), and antihuman melanosome 1:100 (HMB45, Dako, Carpinteria, CA, USA), followed by DAB/HRP detection. Sections were counterstained with Mayer’s hematoxylin solution for 30 s.
+ Open protocol
+ Expand
4

Immunohistochemistry for Melanoma Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunohistochemistry, 5 μm tissue sections were steamed for 20 min with antigen retrieval solution and stained with primary antibodies, SOX10 (A-2, sc-365692; Santa Cruz Biotechnology, Santa Cruz, CA), HMB45 (M0634; Dako, Carpentaria, CA) and S100 (Z0311; Dako, Carpentaria, CA) overnight at 4 °C. On the next day, sections were incubated for 30 min in Imm-PRESS AP Reagent (Vector Laboratories, Burlingame, CA, USA), followed by 5 min incubation with ImmPACT NOVA-RED (Vector Laboratories).
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of Sarcoma Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical analyses were performed on representative tissue blocks using monoclonal antibodies to desmin (clone DE-R11, Dako), smooth muscle actin (SMA, clone 1A4, Dako), TFE3 (clone MRQ-37, Ventana), HMB45 (Dako), Melan-A (clone A103, LICR/in-house), pS6 (clone 91B2, CST) and pAKT(S473) (clone D9E, CST) for cases for which the original stained slides were not available for review. Immunohistochemistry was performed using a Leica Bond-3 automated platform (Leica, Buffalo Grove, IL), and a polymeric secondary kit (Refine, Leica) was used for the detection of the primary antibodies. Immunochemical results were evaluated by experienced histopathologists (RM and RAS) for the intensity of expression (weak, moderate or strong, compared to the intensity of staining of positive control tissue on the same slides) and percentage of tumor cells exhibiting expression. The results for pS6 were converted into an immunoreactive score (IRS), calculated as: intensity of staining (0 absent, 1 weak, 2 moderate, 3 strong) x percentage of cells staining (0–100), yielding IRS scores between 0 and 300. For the few cases for which tissue blocks or unstained slides for immunohistochemistry were not available, the immunohistochemical findings were obtained from the original pathology report issued by MSK gynecologic pathologists at the time of diagnosis.
+ Open protocol
+ Expand
6

Western Blotting Antibody Validation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Following antibodies were used for western blotting: Actin (I-19), Ezrin (C-19), Radixin (C-15), Moesin (C-15), Merlin (B-12), MYPT1 (H-130), c-myc (9E10) from Santa Cruz Biotechnology; CPI-17 (E305) from Epitomics; Ezrin (3C12) from Neomarkers; Ezrin (3145), Radixin (C4G7), phospho-ERM (3149) from Cell Signaling Technology; Moesin (EPR2429(2)) from Abcam; phospho-NF2 S518 from US Biologicals; VSVg from Roche. For Ras, either the antibody from the Active Ras Pulldown and Detection Kit from Thermo Fisher Scientific was used, or Ras (EP1125Y) from Abcam (Figure 4C). For immunoblots of ERM (unless otherwise stated), a mixture of Ezrin (C-19), Radixin (C-15) and Moesin (C-15) antibody was used; for single Ezrin blots, the 3C12 antibody was used. Ezrin (3145), Radixin (C4G7) and Moesin (EPR2429(2)) were used for Figures 1D, 3A, 4A and Supplementary Figure S2. Staining of paraffin sections was performed using anti-CPI-17 from Millipore and HMB45 from DAKO. Ras antibody Y13-259 (Thermo Fisher Scientific) was used for the GEF assay.
+ Open protocol
+ Expand
7

In Vivo Assessment and Histochemical Analysis of Transplanted Eyes

Check if the same lab product or an alternative is used in the 5 most similar protocols

In vivo assessment was performed by spectral domain optical coherence tomography (SD-OCT) (Envisu, Bioptigen) 1 week post transplantation surgery. Histological and immunohistochemical analysis was also performed. Enucleated eyes were cryopreserved according to previously published protocols (Cuenca et al., 2018 (link)). The tenon’s capsule and extraocular muscles were removed as much as possible, and a cut was made around the limbus with a scalpel blade to allow the fixative solution to enter into the eye cavity. Eyes were fixed in 4% paraformaldehyde for 2 h at room temperature. After washing with 0.1 M sodium phosphate buffer (pH 7.4), eyes were immersed in increasing concentrations of sucrose (up to 25%) before freezing. Cryosections (12 mm thickness) were collected and processed for immunofluorescent labeling with anti-Ku80 antibody (rabbit anti-human, 1:200, ab80592, Abcam), and melanosome antibody (mouse anti-human, 1:200, HMB45, Dako). DAPI (4′,6-diamidino-2-phenylindole) was used for nuclear counterstaining (Molecular Probes). Fluorescence images were acquired with a confocal microscope (C2, Nikon).
+ Open protocol
+ Expand
8

Comprehensive Immunohistochemical Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
HE staining: All specimens were fixed by 10% neutral formalin, regularly dehydrated, paraffin-embedded, sectioned into 3-μm sections, and processed for HE staining. IHC staining: IHC staining was performed using the EnVision two-step strategy. Primary antibody information: CD117, HMB45, Desmin, synaptophysin, chromograninA, S100 protein, wide-spectrum cytokeratin, Ki67, and vimentin (DAKO); Bcl2, P53, CD56, CD57 (LEICA); muscle specific actin (MSA), CD34, H-caldesmon (LongIsland); SOX10, INI1, DOG-1 (Gene Tech); somatostatin receptor 2 (SSTR2), somatostatin receptor 5 (SSTR5) (Abcam); α-smooth muscle actin (α-SMA) (Thermo); ATRX (Sigma); calponin, Collagen type IV (MXB Biotechnologies); BRAF V600E (ZSGB Biotechnology). The dilutions, clone and sources of these antibodies were listed in Table 1.
+ Open protocol
+ Expand
9

Immunohistochemical Analysis of Sebaceous Glands

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 171 biopsy samples of the facial skin and the scalp which were randomly selected from the pathologic archives of the Department of Dermatology, Kyungpook National University Hospital, were used for the study. H&E staining of all samples (blocks of paraffin-embedded tissues) were reviewed retrospectively, and 103 samples with SGs were identified. Among them, 54 slides were already stained with the antiserum to S-100 (Dako, Ely, UK), 7 with antiserum to human melanoma black-45 (HMB-45; Dako), 11 with Fontana-Masson (F-M) stain (Junsei Chemical Co., Ltd., Tokyo, Japan), 4 with antiserum to CD1a (Novocastra, Newcastle, UK), 7 with antiserum to c-kit (Dako, Glostrup, Denmark), 10 with antiserum to microphthalmia-associated transcription factor (MITF; Leica Biosystems, Newcastle, UK), and 10 with antiserum to tyrosinase (Thermo Scientific, Fremont, CA, USA). All tissue sections contained epidermal melanocytes and Langerhans cells, which served as internal positive controls (Fig. 1).
+ Open protocol
+ Expand
10

Comprehensive Immunohistochemical Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The tissue samples were fixed with 10% neutral formalin and embedded in paraffin. Tissue sections of 4 ~ 5 μm thickness were prepared and stained with hematoxylin and eosin (H&E), and additional sections were stained with Congo red. Immunohistochemical staining was performed using Dako EnVision Peroxidase detection system on Roche Ventana Benchmark XT autostainer (Ventana Medical Systems, Tucson, AZ). The primary antibodies panel consisted of calcitonin (CT) (clone SP17, Ready-to-Use), chromogranin A (CgA) (SP12, Ready-to-Use), synaptophysin (Syn) (SY38, 1:100), CD56 (1B6, 1:50, Novocastra, Newcastle upon Tyne, UK), TTF-1 (SPT24, prediluted), Thyroglobulin (TG) (2H11 + 6E1), Ki-67 (MIB-1, 1:100), carcinoembryonic antigen (CEA) (12–140-10, Ready-to-Use), cytokeratin (AE1/AE3, Ready-to-Use), epithelial membrane antigen (EMA) (E29, 1:100), vimentin (V9, 1:100), desmin (D33, 1:160), alpha-smooth muscle actin (SMA) (lA4, 1:100, Dako), HMB45 (HMB-45, 1:50), S-100 protein (polyclonal,1:200), HBME-1 (HBME-1, Ready-to-Use), galectin-3 (9C4, Ready-to-Use), CK19 (A53-B/A2.26, Ready-to-Use), and CD99 (12E7, 1:50). Unless otherwise stated, all antibodies were mouse monoclonal and from DAKO Corporation (Dako North America, Inc., Carpinteria, CA, USA). Appropriate positive and negative controls were run in parallel.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!